Lv1
68 积分 2026-02-07 加入
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
3天前
已完结
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer
1个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
3个月前
已完结
Development of Novel 111In/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics
4个月前
已完结
Porphyrins modified fibroblast activation protein inhibitor for enhanced cancer radionuclide therapy
4个月前
已完结
[177Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma
5个月前
已完结
Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [68Ga]Ga-FAPI-FUSCC-II
5个月前
已完结
Linker-Driven Breakthrough: Design of a Novel Linker for Enhanced Theranostic Performance of FAPI Trimer
5个月前
已完结
An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy
6个月前
已完结
皖公网安备34019202002308
